Concepedia

Neelam Shah

NS

Statistics

Publications

2

Citations

132

H-Index

2

Active since

2021

Affiliations

AstraZeneca (United Kingdom)(Current)

Neelam Shah is an author at AstraZeneca (United Kingdom) specializing in phase ii investigation, oncology, and medicine.

Publications per year

2021–2021

2

Publications

2

Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapy

R. Kim, Minsuk Kwon, Minae An et al. · Annals of Oncology · 2021 · 115 citations · Full text

, , +16

512O Interim results from a phase II study of the ATR inhibitor ceralasertib in ARID1A-deficient and ARID1A-intact advanced solid tumor malignancies

Rahul Aggarwal, Sarah E. Umetsu, Mallika Dhawan et al. · Annals of Oncology · 2021 · 17 citations · Full text

, , +13

1–2 of 2